La Jolla Pharmaceutical Co
LJPCDelisted Aug 22, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000920465
La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding La Jolla Pharmaceutical Co changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 45 | 41 | −4 |
| Shares | 16.5M | 16.9M | +388.6K (+2.4%) |
| Value | $70.4M | $53.9M | −$16.6M (−23.5%) |
New holders (2)
Institutions that held La Jolla Pharmaceutical Co at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Old National Bancorp | 41,284 | $132.0K | 0.00% |
| Advisor Group Holdings, Inc. | 1,400 | $4.00K | 0.00% |
Sold out (6)
Institutions that held La Jolla Pharmaceutical Co at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 50,873 | $217.0K |
| Two Sigma Advisers, LP | 34,900 | $149.0K |
| Two Sigma Investments, LP | 27,544 | $118.0K |
| Goldman Sachs Group Inc | 13,718 | $59.0K |
| Occudo Quantitative Strategies LP | 13,541 | $58.0K |
| American Portfolios Advisors | 1,000 | $4.27K |